287 related articles for article (PubMed ID: 17652272)
1. Study affirms PhRMA's influence on physicians.
Miller JD
J Natl Cancer Inst; 2007 Aug; 99(15):1148-50. PubMed ID: 17652272
[No Abstract] [Full Text] [Related]
2. The high cost of free lunch.
Rankin RC
Obstet Gynecol; 2007 Oct; 110(4):932. PubMed ID: 17906040
[No Abstract] [Full Text] [Related]
3. The high cost of free lunch.
Randall DA
Obstet Gynecol; 2007 Oct; 110(4):932; author reply 932-3. PubMed ID: 17906039
[No Abstract] [Full Text] [Related]
4. The high cost of free lunch.
Frohlich EP
Obstet Gynecol; 2007 Oct; 110(4):931; author reply 932-3. PubMed ID: 17906038
[No Abstract] [Full Text] [Related]
5. The high cost of free lunch.
Campbell WA
Obstet Gynecol; 2007 Oct; 110(4):931-2; author reply 932-3. PubMed ID: 17906037
[No Abstract] [Full Text] [Related]
6. Doctors and drug companies.
Lambert LA
N Engl J Med; 2005 Feb; 352(7):733-4; author reply 733-4. PubMed ID: 15716575
[No Abstract] [Full Text] [Related]
7. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
Wofford JL; Ohl CA
BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
[TBL] [Abstract][Full Text] [Related]
8. For sale: physicians' prescribing data.
Steinbrook R
N Engl J Med; 2006 Jun; 354(26):2745-7. PubMed ID: 16807410
[No Abstract] [Full Text] [Related]
9. Pharmaceutical marketing: nurses are also targeted.
Prescrire Int; 2010 Aug; 19(108):190. PubMed ID: 20939464
[No Abstract] [Full Text] [Related]
10. High-tech stealth being used to sway doctor prescriptions.
Stolberg SG; Gerth J
N Y Times Web; 2000 Nov; ():A1, A22. PubMed ID: 12159839
[No Abstract] [Full Text] [Related]
11. On the need for probity when physicians interact with industry.
Scott IA
Intern Med J; 2006 Apr; 36(4):265-9. PubMed ID: 16640747
[TBL] [Abstract][Full Text] [Related]
12. Marketing drugs: debating the real cost. Concern about close ties between doctors and pharmaceutical firms are prompting new financial disclosure laws and education efforts.
Brand R
State Legis; 2008 Sep; 34(8):26-9. PubMed ID: 18754159
[No Abstract] [Full Text] [Related]
13. The gift of drug samples.
Reid EE
Hastings Cent Rep; 2012; 42(2):49. PubMed ID: 22733332
[No Abstract] [Full Text] [Related]
14. The high cost of free lunch.
Wall LL; Brown D
Obstet Gynecol; 2007 Jul; 110(1):169-73. PubMed ID: 17601912
[TBL] [Abstract][Full Text] [Related]
15. PhRMA's Code on Interactions with Healthcare Professionals.
Bieri D
Am J Bioeth; 2010 Oct; 10(10):18. PubMed ID: 20945263
[No Abstract] [Full Text] [Related]
16. Cheap trinkets, effective marketing: small gifts from drug companies to physicians.
Brett AS
Am J Bioeth; 2003; 3(3):52-4. PubMed ID: 14594493
[No Abstract] [Full Text] [Related]
17. The death of common sense.
Trachtman H
Am J Bioeth; 2003; 3(3):W31-W32. PubMed ID: 14594484
[No Abstract] [Full Text] [Related]
18. A national survey of physician-industry relationships.
Sade RM
N Engl J Med; 2007 Aug; 357(5):507; author reply 508. PubMed ID: 17671263
[No Abstract] [Full Text] [Related]
19. Why self-regulation does not work: resolving prescription corruption caused by excessive gift-giving by pharmaceutical manufacturers.
Mehta RS
Food Drug Law J; 2008; 63(4):799-821. PubMed ID: 19593922
[No Abstract] [Full Text] [Related]
20. The invisible influence of industry inducements.
Rhodes R; Capozzi JD
Am J Bioeth; 2003; 3(3):65-7. PubMed ID: 14594501
[No Abstract] [Full Text] [Related]
[Next] [New Search]
